TFC Financial Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,854
Closed -$51K 604
2021
Q2
$51K Hold
1,854
0.02% 203
2021
Q1
$31K Hold
1,854
0.01% 222
2020
Q4
$34K Hold
1,854
0.01% 215
2020
Q3
$25K Buy
+1,854
New +$28.6K 0.01% 223

TFC Financial Management's TBIO Position: Q3 2021 in Review

TFC Financial Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,854 shares — an estimated $51K sold.

TFC Financial Management first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $51K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • TFC Financial Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • TFC Financial Management sold 1,854 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $51K.
  • TFC Financial Management first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • TFC Financial Management's Translate Bio, Inc. Common Stock position peaked at $51K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on TFC Financial Management's 13F filing for Q3 2021, filed 2 Nov 2021.